|
SQLE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.82259998602075E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.46240028367595E-10 |
| Normal-vs-Stage2 |
5.14530000050861E-07 |
| Normal-vs-Stage3 |
4.644400E-02 |
| Normal-vs-Stage4 |
9.674200E-01 |
| Stage1-vs-Stage2 |
9.435600E-01 |
| Stage1-vs-Stage3 |
6.277700E-03 |
| Stage1-vs-Stage4 |
1.359150E-01 |
| Stage2-vs-Stage3 |
4.977600E-02 |
| Stage2-vs-Stage4 |
1.466960E-01 |
| Stage3-vs-Stage4 |
4.554800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50830004042035E-09 |
| Normal-vs-AfricanAmerican |
3.33669999996733E-06 |
| Normal-vs-Asian |
1.013620E-01 |
| Caucasian-vs-AfricanAmerican |
4.870400E-01 |
| Caucasian-vs-Asian |
2.632400E-01 |
| AfricanAmerican-vs-Asian |
3.176200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62569957495862E-12 |
| Normal-vs-Female |
8.878300E-02 |
| Male-vs-Female |
3.034200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.211700E-04 |
| Normal-vs-Extreme_Weight |
1.64390723256247E-12 |
| Normal-vs-Obese |
6.33940000049904E-07 |
| Normal-vs-Extreme_Obese |
4.356100E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.695600E-02 |
| Normal_Weight-vs-Obese |
5.146200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.841200E-01 |
| Extreme_Weight-vs-Obese |
5.058000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.734800E-01 |
| Obese-vs-Extreme_Obese |
7.812200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.252600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.47369999536906E-08 |
| Normal-vs-Age(61-80Yrs) |
2.10130024491662E-10 |
| Normal-vs-Age(81-100Yrs) |
1.76529901807498E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.536350E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.383400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.675400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.640200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.477900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.046500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.6292301669173E-12 |
| Normal-VS-Type2 PRCC |
4.49900117160951E-11 |
| Normal-VS-KIRP CIMP |
3.833800E-02 |
| Normal-VS-Unclassified PRCC |
1.560030E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.772800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.801240E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.756600E-04 |
| Type2 PRCC-VS-KIRP CIMP |
3.518200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.168500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.858400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85239601435683E-11 |
| Normal-vs-N1 |
7.845800E-01 |
| Normal-vs-N2 |
6.331200E-01 |
| N0-vs-N1 |
3.139900E-03 |
| N0-vs-N2 |
3.263400E-01 |
| N1-vs-N2 |
6.063600E-01 |
|
|
